{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:04:22Z","timestamp":1787652262693,"version":"build-2736575974"},"reference-count":58,"publisher":"Scientific Scholar","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Considerable progress has been made in the field of leptospiral vaccines development since its first use as a killed vaccine in guinea pigs. Despite the fact that the immunity conferred is restricted to serovars with closely related lipopolysaccharide antigen, certain vaccines have remained useful, especially in endemic regions, for the protection of high-risk individuals. Other conventional vaccines such as the live-attenuated vaccine and lipopolysaccharide (LPS) vaccine have not gained popularity due to the reactive response that follows their administration and the lack of understanding of the pathogenesis of leptospirosis. With the recent breakthrough and availability of complete genome sequences of <jats:italic toggle=\"yes\">Leptospira<\/jats:italic>, development of novel vaccine including recombinant protein vaccine using reverse vaccinology approaches has yielded encouraging results. However, factors hindering the development of effective leptospiral vaccines include variation in serovar distribution from region to region, establishment of renal carrier status following vaccination and determination of the dose and endpoint titres acceptable as definitive indicators of protective immunity. In this review, advancements and progress made in LPS-based vaccines, killed- and live-attenuated vaccines, recombinant peptide vaccines and DNA vaccines against leptospirosis are highlighted.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_1022_16","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T05:47:37Z","timestamp":1525758457000},"page":"15-22","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":40,"title":["Advances &amp; challenges in leptospiral vaccine development"],"prefix":"10.25259","volume":"147","author":[{"given":"Garba","family":"Bashiru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rani","family":"Bahaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-5-20241212","doi-asserted-by":"crossref","first-page":"e0003898","DOI":"10.1371\/journal.pntd.0003898","article-title":"Global morbidity and mortality of leptospirosis: A Systematic review","volume":"9","author":"Costa","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"R2-5-20241212","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1128\/CMR.14.2.296-326.2001","article-title":"Leptospirosis","volume":"14","author":"Levett","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"R3-5-20241212","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijid.2007.09.011","article-title":"The globalization of leptospirosis: Worldwide incidence trends","volume":"12","author":"Pappas","year":"2008","journal-title":"Int J Infect Dis"},{"key":"R4-5-20241212","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/01.qco.0000178824.05715.2c","article-title":"Leptospirosis","volume":"18","author":"McBride","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"R5-5-20241212","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.vetmic.2009.03.012","article-title":"Leptospira and leptospirosis","volume":"140","author":"Adler","year":"2010","journal-title":"Vet Microbiol"},{"key":"R6-5-20241212","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(03)00830-2","article-title":"Leptospirosis: A zoonotic disease of global importance","volume":"3","author":"Bharti","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"R7-5-20241212","first-page":"1","article-title":"History of leptospirosis and Leptospira","volume":"387","author":"Adler","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"R8-5-20241212","first-page":"65","article-title":"Leptospirosis in humans","volume":"387","author":"Haake","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"R9-5-20241212","first-page":"251","article-title":"Vaccines against leptospirosis","volume":"387","author":"Adler","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"R10-5-20241212","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10393-017-1234-0","article-title":"Retrospective study of leptospirosis in Malaysia","volume":"14","author":"Garba","year":"2017","journal-title":"EcoHealth"},{"key":"R11-5-20241212","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1128\/IAI.69.11.6831-6838.2001","article-title":"Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination","volume":"69","author":"Branger","year":"2001","journal-title":"Infect Immun"},{"key":"R12-5-20241212","first-page":"375","article-title":"Lipopolysaccharide biosynthesis in leptospira","volume":"2","author":"Bulach","year":"2000","journal-title":"J Mol Microbiol Biotechnol"},{"key":"R13-5-20241212","doi-asserted-by":"crossref","first-page":"e0003898","DOI":"10.1371\/journal.pntd.0003898","article-title":"Global morbidity and mortality of leptospirosis: A Systematic review","volume":"9","author":"Costa","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"R14-5-20241212","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.4161\/hv.7.11.17944","article-title":"Recombinant vaccines against leptospirosis","volume":"7","author":"Dellagostin","year":"2011","journal-title":"Hum Vaccin"},{"key":"R15-5-20241212","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.actatropica.2017.12.010","article-title":"Major epidemiological factors associated with leptospirosis in Malaysia","volume":"178","author":"Garba","year":"2017","journal-title":"Acta tropica"},{"key":"R16-5-20241212","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/03079450220136567a","article-title":"Comparison of an attenuated anticoccidial vaccine and an anticoccidial drug programme in commercial broiler chickens in Italy","volume":"31","author":"Williams","year":"2002","journal-title":"Avian Pathol"},{"key":"R17-5-20241212","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1475-2859-6-39","article-title":"Leptospirosis vaccines","volume":"6","author":"Wang","year":"2007","journal-title":"Microb Cell Fact"},{"key":"R18-5-20241212","first-page":"210","article-title":"Leptospirosis vaccines: Past, present, and future","volume":"51","author":"Koizumi","year":"2005","journal-title":"J Postgrad Med"},{"key":"R19-5-20241212","first-page":"139","article-title":"The molecular basis of leptospiral pathogenesis","volume":"387","author":"Murray","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"R20-5-20241212","first-page":"43","article-title":"Genomics, proteomics, and genetics of leptospira","volume":"387","author":"Picardeau","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"R21-5-20241212","first-page":"12","article-title":"Protection of gilts against leptospirosis by use of a live vaccine","volume":"14","author":"Fish","year":"1973","journal-title":"Can Vet J"},{"key":"R22-5-20241212","first-page":"1671","article-title":"Vaccination against leptospirosis: Protection of hamsters and swine against renal leptospirosis by killed but intact gamma-irradiated or dihydrostreptomycin-exposed Leptospira pomona","volume":"28","author":"Stalheim","year":"1967","journal-title":"Am J Vet Res"},{"key":"R23-5-20241212","first-page":"452","article-title":"Comparison of Leptospira pomona bacterin and attenuated live culture vaccine for control of abortion in cattle","volume":"139","author":"Kenzy","year":"1961","journal-title":"J Am Vet Med Assoc"},{"key":"R24-5-20241212","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/infdis\/jiq127","article-title":"Cross-protective immunity against leptospirosis elicited by a live, attenuated lipopolysaccharide mutant","volume":"203","author":"Srikram","year":"2011","journal-title":"J Infect Dis"},{"key":"R25-5-20241212","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0255-0857(21)02314-8","article-title":"Prospects of developing leptospiral vaccines for animals","volume":"24","author":"Srivastava","year":"2006","journal-title":"Indian J Med Microbiol"},{"key":"R27-5-20241212","first-page":"99","article-title":"Animal leptospirosis","volume":"387","author":"Ellis","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"R28-5-20241212","doi-asserted-by":"crossref","first-page":"7550","DOI":"10.1128\/IAI.69.12.7550-7558.2001","article-title":"Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes","volume":"69","author":"Naiman","year":"2001","journal-title":"Infect Immun"},{"key":"R31-5-20241212","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ijid.2010.02.613","article-title":"Vax-SPIRAL\u00ae: Cuban antileptospirosis vaccines for humans: Clinical and field assays and impact of the vaccine on the disease after 11 years of application in Cuba","volume":"14","author":"Mart\u00ednez","year":"2010","journal-title":"Int J Infect Dis"},{"key":"R32-5-20241212","first-page":"249","article-title":"Efficacy and safety of a vaccine against human leptospirosis in Cuba","volume":"15","author":"Mart\u00ednez","year":"2004","journal-title":"Rev Panam Salud Publica"},{"key":"R33-5-20241212","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0264-410X(00)00129-8","article-title":"Evidence of cross-protection within Leptospira interrogans in an experimental model","volume":"19","author":"Sonrier","year":"2000","journal-title":"Vaccine"},{"key":"R34-5-20241212","first-page":"245","article-title":"Recent advances in canine leptospirosis: Focus on vaccine development","volume":"6","author":"Adler","year":"2015","journal-title":"Vet Med Res Rep"},{"key":"R35-5-20241212","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1590\/S0100-879X2004000400003","article-title":"Genome features of Leptospira interrogans serovar copenhageni","volume":"37","author":"Nascimento","year":"2004","journal-title":"Braz J Med Biol Res"},{"key":"R36-5-20241212","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.vaccine.2007.10.052","article-title":"Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge","volume":"26","author":"Seixas","year":"2007","journal-title":"Vaccine"},{"key":"R37-5-20241212","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/86354","article-title":"Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism","volume":"2","author":"Werts","year":"2001","journal-title":"Nat Immunol"},{"key":"R38-5-20241212","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1099\/00222615-29-2-115","article-title":"Experimental immunisation of hamsters with lipopolysaccharide antigens of Leptospira interrogans","volume":"29","author":"Jost","year":"1989","journal-title":"J Med Microbiol"},{"key":"R39-5-20241212","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1099\/00222615-22-3-269","article-title":"A monoclonal antibody reacting with a determinant on leptospiral lipopolysaccharide protects guinea pigs against leptospirosis","volume":"22","author":"Jost","year":"1986","journal-title":"J Med Microbiol"},{"key":"R40-5-20241212","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1586\/14760584.2015.1026808","article-title":"Biosynthetically engineered lipopolysaccharide as vaccine adjuvant","volume":"14","author":"Zariri","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"R41-5-20241212","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2165\/00003495-200363100-00006","article-title":"Recombinant hepatitis B vaccine (Engerix-B): A review of its immunogenicity and protective efficacy against hepatitis B","volume":"63","author":"Keating","year":"2003","journal-title":"Drugs"},{"key":"R42-5-20241212","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vaccine.2007.10.029","article-title":"Evaluation of protective immunity of leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters","volume":"26","author":"Faisal","year":"2008","journal-title":"Vaccine"},{"key":"R43-5-20241212","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1128\/IAI.68.4.2276-2285.2000","article-title":"The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during Mammalian infection","volume":"68","author":"Haake","year":"2000","journal-title":"Infect Immun"},{"key":"R44-5-20241212","first-page":"779","article-title":"Comparison of immunoprotection of leptospira recombinant proteins with conventional vaccine in experimental animals","volume":"53","author":"Parthiban","year":"2015","journal-title":"Indian J Exp Biol"},{"key":"R45-5-20241212","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/IAI.74.3.1745-1750.2006","article-title":"Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar pomona infection","volume":"74","author":"Palaniappan","year":"2006","journal-title":"Infect Immun"},{"key":"R46-5-20241212","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1080\/21645515.2015.1047117","article-title":"Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45","volume":"11","author":"Vijayachari","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"R47-5-20241212","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0749-0720(15)30532-6","article-title":"Leptospirosis as a cause of reproductive failure","volume":"10","author":"Ellis","year":"1994","journal-title":"Vet Clin North Am Food Anim Pract"},{"key":"R48-5-20241212","first-page":"75","article-title":"OmpL1 DNA vaccine cross-protects against heterologous Leptospira spp. Challenge","volume":"25","author":"Maneewatch","year":"2007","journal-title":"Asian Pac J Allergy Immunol"},{"key":"R49-5-20241212","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1128\/IAI.67.12.6572-6582.1999","article-title":"Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection","volume":"67","author":"Haake","year":"1999","journal-title":"Infect Immun"},{"key":"R50-5-20241212","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1128\/iai.57.8.2502-2506.1989","article-title":"Immunological characteristics of the glycolipid antigen of Leptospira interrogans serovar lai","volume":"57","author":"Masuzawa","year":"1989","journal-title":"Infect Immun"},{"key":"R51-5-20241212","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1348-0421.2000.tb02579.x","article-title":"Control of immunologically crossreactive Leptospiral infection by administration of lipopolysaccharides from a nonpathogenic strain of Leptospira biflexa","volume":"44","author":"Matsuo","year":"2000","journal-title":"Microbiol Immunol"},{"key":"R52-5-20241212","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/01.qco.0000178824.05715.2c","article-title":"Leptospirosis","volume":"18","author":"McBride","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"R53-5-20241212","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1099\/00222615-33-3-199","article-title":"Vaccination of mice with lipopolysaccharide (LPS) and LPS-derived immuno-conjugates from Leptospira interrogans","volume":"33","author":"Midwinter","year":"1990","journal-title":"J Med Microbiol"},{"key":"R54-5-20241212","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/CVI.05720-11","article-title":"Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin","volume":"19","author":"Grassmann","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"R55-5-20241212","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.vaccine.2008.10.089","article-title":"Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity","volume":"27","author":"Faisal","year":"2009","journal-title":"Vaccine"},{"key":"R56-5-20241212","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.immunol.15.1.617","article-title":"DNA vaccines","volume":"15","author":"Donnelly","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"R57-5-20241212","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1128\/IAI.73.7.4062-4069.2005","article-title":"Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1","volume":"73","author":"Branger","year":"2005","journal-title":"Infect Immun"},{"key":"R58-5-20241212","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0006-2952(97)00529-7","article-title":"Plasmid DNA: A new era in vaccinology","volume":"55","author":"Mor","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"R59-5-20241212","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1385\/MB:19:3:245","article-title":"Plasmid DNA vaccines. Immunology, tolerance, and autoimmunity","volume":"19","author":"Mor","year":"2001","journal-title":"Mol Biotechnol"},{"key":"R60-5-20241212","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1580\/1080-6032(2005)16[129:LIACRF]2.0.CO;2","article-title":"Leptospirosis in a caver returned from Sarawak, Malaysia","volume":"16","author":"Mortimer","year":"2005","journal-title":"Wilderness Environ Med"},{"key":"R61-5-20241212","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijmm.2004.03.001","article-title":"Bacteria as DNA vaccine carriers for genetic immunization","volume":"294","author":"Schoen","year":"2004","journal-title":"Int J Med Microbiol"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201847010-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:59:52Z","timestamp":1751497192000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/advances-challenges-in-leptospiral-vaccine-development\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_1022_16","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}